Stoke Therapeutics inks $90 mln Series B
Bedford, Massachusetts-based Stoke Therapeutics, a biotech firm, has raised $90 million in Series B financing. RTW Investments led the round with participation from other investors that included Apple Tree Partners, RA Capital Management, Cormorant Asset Management, Perceptive Advisors, funds managed by Janus Henderson Investors, Redmile Group, Sphera Funds Management and Alexandria Venture Investments.
23 October 2018•1 min read
